Collagen-induced p38 MAP kinase activation is a biomarker of platelet hyper-aggregation in patients with diabetes mellitus.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Life Science

• Publication date

  2009-08-26

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.lfs.2009.07.003PMID 19631227
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Two distinct roles of mitogen-activated protein kinases in platelets and a novel Rac1-MAPK-dependent integrin outside-in retractile signaling pathway.

  2009cited by this paper
• Future innovations in anti‐platelet therapies

  2008cited by this paper
• HSP27 phosphorylation is correlated with ADP-induced platelet granule secretion.

  2008cited by this paper
• Platelet signalling abnormalities in patients with type 2 diabetes mellitus: a review.

  2008cited by this paper
• Platelet hyperactivity in type 2 diabetes: role of antiplatelet agents

  2008cited by this paper
• Aspirin for primary prevention of atherosclerotic disease in Japan.

  2007cited by this paper
• In vitro glycoxidized low-density lipoproteins and low-density lipoproteins isolated from type 2 diabetic patients activate platelets via p38 mitogen-activated protein kinase.

  2007cited by this paper
• Thrombin stimulation of p38 MAP kinase in human platelets is mediated by ADP and thromboxane A2 and inhibited by cGMP/cGMP-dependent protein kinase.

  2007cited by this paper
• AHA/ADA vs. ESC/EASD recommendations on aspirin as a primary prevention strategy in people with diabetes: how the same data generate divergent conclusions.

  2007cited by this paper
• Essential role of protein kinase C delta in platelet signaling, alpha IIb beta 3 activation, and thromboxane A2 release.

  2006influential reference
• Aspirin resistance.

  2006cited by this paper
• C-reactive protein (CRP)-lowering agents.

  2006cited by this paper
• P2Y12 receptors play a significant role in the development of platelet microaggregation in patients with diabetes.

  2005cited by this paper
• Differential Involvement of ERK2 and p38 in Platelet Adhesion to Collagen*

  2005influential reference
• Aspirin resistance

  2004cited by this paper
• Aspirin resistance

  2004cited by this paper
• Activation of p38 mitogen-activated protein kinase/cytosolic phospholipase A2 cascade in hydroperoxide-stressed platelets.

  2003cited by this paper
• Diabetes mellitus: a hypercoagulable state.

  2001cited by this paper
• Epinephrine--via activation of p38-MAPK--abolishes the effect of aspirin on platelet deposition to collagen.

  2001cited by this paper
• Role of the ERK Pathway in the Activation of Store-mediated Calcium Entry in Human Platelets*

  2001cited by this paper
• The role of platelets in diabetes-related vascular complications.

  2000cited by this paper
• Mitogen-activated protein kinase: conservation of a three-kinase module from yeast to human.

  1999cited by this paper
• Circulating intercellular adhesion molecule-1, vascular cell adhesion molecule-1, and E-selectin in patients with type 2 diabetes mellitus.

  1999cited by this paper
• Enzyme-Linked Immunosorbent Assay for Measurement of JNK, ERK, and p38 Kinase Activities

  1998cited by this paper
• Immunodetection of activated mitogen-activated protein kinase in vascular tissues

  1997cited by this paper
• Diabetes mellitus, hypercholesterolemia, and hypertension but not vascular disease per se are associated with persistent platelet activation in vivo. Evidence derived from the study of peripheral arterial disease.

  1997cited by this paper
• Aspirin Therapy in Diabetes

  1997cited by this paper
• Platelet-dependent thrombin generation in patients with diabetes mellitus: effects of glycemic control on coagulability in diabetes.

  1996cited by this paper
• Role for p38 Mitogen-activated Protein Kinase in Platelet Aggregation Caused by Collagen or a Thromboxane Analogue (*)

  1996influential reference
• Modulation of the Stress‐Induced Synthesis of hsp27 and αB‐Crystallin by Cyclic AMP in C6 Rat Glioma Cells

  1996cited by this paper
• SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin‐1

  1995cited by this paper
• Spontaneous platelet aggregation in whole blood is increased in non-insulin-dependent diabetes mellitus and in female but not male patients with primary dyslipidemia.

  1995cited by this paper
• Platelet Plasminogen Activator Inhibitor 1 in Patients With Type II Diabetes

  1994cited by this paper
• The study of platelet aggregation in whole blood [proceedings].

  1979cited by this paper
• Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

  1970cited by this paper
• Effects of the Numbers and Sizes of Platelet Aggregates on the Optical Density of Plasma

  1967cited by this paper

• Black Soldier Fly Larvae Oil: A Functional Lipid that Improves Insulin Sensitivity Mainly by Inhibiting the PPAR and MAPK Signaling

  2025cites this paper
• The roles of MAPK signaling pathway in ovarian folliculogenesis

  2025cites this paper
• Effect of irisin on ovarian phosphatidylinositol‐3‐kinase/protein kinase B signaling pathway and mitogen‐activated protein kinase/extracellular signal‐regulated kinase pathways of rats with polycystic ovary syndrome

  2024cites this paper
• Pentadecanoic acid (C15:0, PA) induces mild maternal glucose intolerance and promotes the growth of the offspring partly through up-regulating liver PPARα and MAPK signaling pathways.

  2024cites this paper
• Inverse relationship between platelet Akt activity and hippocampal atrophy: A pilot case-control study in patients with diabetes mellitus

  2024cites this paper
• Relationship between the Responsiveness of Amyloid β Protein to Platelet Activation by TRAP Stimulation and Brain Atrophy in Patients with Diabetes Mellitus

  2022cites this paper
• Pimpinellin Inhibits Collagen-induced Platelet Aggregation and Activation Through Inhibiting Granule Secretion and PI3K/Akt Pathway

  2021cites this paper
• Synergistic effect of collagen and CXCL12 in the low doses on human platelet activation

  2020cites this paper
• Berberine decreases insulin resistance in a PCOS rats by improving GLUT4: Dual regulation of the PI3K/AKT and MAPK pathways.

  2019cites this paper
• Smoking cessation affects human platelet activation induced by collagen

  2019cites this paper
• The release of phosphorylated-HSP27 from activated platelets of obstructive sleep apnea syndrome (OSAS) patients.

  2019cites this paper
• Ristocetin induces phosphorylated-HSP27 (HSPB1) release from the platelets of type 2 DM patients: Anti-platelet agent-effect on the release.

  2018cites this paper
• Sphingosine 1-phosphate (S1P) suppresses the collagen-induced activation of human platelets via S1P4 receptor.

  2017cites this paper
• Thrombin Receptor-Activating Protein (TRAP)-Activated Akt Is Involved in the Release of Phosphorylated-HSP27 (HSPB1) from Platelets in DM Patients

  2016cites this paper
• Factor Xa Inhibitor Suppresses the Release of Phosphorylated HSP27 from Collagen-Stimulated Human Platelets: Inhibition of HSP27 Phosphorylation via p44/p42 MAP Kinase

  2016cites this paper
• AICAR reduces the collagen-stimulated secretion of PDGF-AB and release of soluble CD40 ligand from human platelets: Suppression of HSP27 phosphorylation via p44/p42 MAP kinase.

  2016cites this paper
• Platelet Activation in Human Immunodeficiency Virus Type-1 Patients Is Not Altered with Cocaine Abuse

  2015cites this paper
• Release of Phosphorylated HSP27 (HSPB1) from Platelets Is Accompanied with the Acceleration of Aggregation in Diabetic Patients

  2015cites this paper
• Significant correlation between the acceleration of platelet aggregation and phosphorylation of HSP27 at Ser-78 in diabetic patients.

  2012cites this paper